{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:59:10Z","timestamp":1767855550903,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006107","name":"Gil Medical Center, Gachon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.11.015","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:49:04Z","timestamp":1574988544000},"page":"730-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness of a single dose of the quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, in the Korean Armed Forces"],"prefix":"10.1016","volume":"38","author":[{"given":"Jae Hyoung","family":"Im","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeongtaek","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Man","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon-Hyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4856-3668","authenticated-orcid":false,"given":"Jaehun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.015_b0005","unstructured":"Mandell G. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 7th ed. 2011;12."},{"key":"10.1016\/j.vaccine.2019.11.015_b0010","unstructured":"Meningococcal Vaccination for Adolescents: Information for Healthcare Professionals: https:\/\/www.cdc.gov\/vaccines\/vpd\/mening\/hcp\/adolescent-vaccine.html Centers for Diseases Control and Prevention."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.11.015_b0015","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/648964","article-title":"Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines","volume":"50","author":"Poland","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2019.11.015_b0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","journal-title":"J Med Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.11.015_b0025","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1345\/aph.1G486","article-title":"Update on prevention of meningococcal disease: focus on tetravalent meningococcal conjugate vaccine","volume":"40","author":"Mehlhorn","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"Rr-2","key":"10.1016\/j.vaccine.2019.11.015_b0030","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.015_b0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3346\/jkms.2003.18.2.163","article-title":"Meningococcal disease in the republic of Korea army: incidence and serogroups determined by PCR","volume":"18","author":"Lee","year":"2003","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2019.11.015_b0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3346\/jkms.2015.30.4.353","article-title":"Vaccination policy in Korean armed forces: current status and future challenge","volume":"30","author":"Heo","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"7","key":"10.1016\/j.vaccine.2019.11.015_b0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3346\/jkms.2017.32.7.1111","article-title":"Characterization of oropharyngeal carriage isolates of Neisseria meningitidis in healthy Korean adolescents in 2015","volume":"32","author":"Kim","year":"2017","journal-title":"J Korean Med Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.015_b0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3947\/ic.2016.48.1.12","article-title":"A survey of serum bactericidal antibodies against Neisseria meningitidis serogroups A, C, W and Y in adolescents and adults in the Republic of Korea","volume":"48","author":"Kang","year":"2016","journal-title":"Infect Chemother"},{"key":"10.1016\/j.vaccine.2019.11.015_b0055","first-page":"188","article-title":"The changes of meningococcal carriage rate and the serogroup in Korean army recruits","volume":"41","author":"Hwang","year":"2010","journal-title":"J Korean Mil Med Assoc"},{"issue":"10","key":"10.1016\/j.vaccine.2019.11.015_b0060","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1016\/j.ijid.2010.03.017","article-title":"Safety and immunogenicity of an investigational quadrivalent meningococcal CRM (197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America","volume":"14","author":"Stamboulian","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.015_b0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/599117","article-title":"Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents","volume":"49","author":"Jackson","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.11.015_b0070","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00207-09","article-title":"Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra","volume":"16","author":"Reisinger","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.11.015_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2016.02.010","article-title":"Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW-D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea","volume":"45","author":"Kim","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.015_b0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijid.2014.06.008","article-title":"Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults","volume":"28","author":"Lee","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.11.015_b0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/INF.0b013e31820a8b3c","article-title":"Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine","volume":"30","author":"Macneil","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.015_b0090","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2193","article-title":"Effectiveness and duration of protection of one dose of a meningococcal conjugate vaccine","volume":"139","author":"Cohn","year":"2017","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2019.11.015_b0095","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3349\/ymj.2016.57.6.1511","article-title":"Immunogenicity of MenACWY-CRM in Korean military recruits: Influence of tetanus-diphtheria toxoid vaccination on the vaccine response to MenACWY-CRM","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"issue":"6","key":"10.1016\/j.vaccine.2019.11.015_b0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7883\/yoken.JJID.2008.434","article-title":"Serological and genetic characterization of meningococcal isolates in Korea","volume":"61","author":"Bae","year":"2008","journal-title":"Jpn J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:27Z","timestamp":1759401507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19315385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19315385"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of a single dose of the quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, in the Korean Armed Forces","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}